A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test the hypothesis that appendicular lean body
mass (aLBM) will increase after 12 weeks of LY2495655 treatment versus placebo in older
participants undergoing elective total hip arthroplasty (eTHA).